EGF and cancer: In BC, palmitoylation controls the function of estrogen receptors, the epidermal growth factor (EGF) family of receptors, and cancer stem cell markers, influencing cell–cell communication and enhancing cancer metastatic ability by interacting with stroma and immune cells, and aberrant palmitoylation contributes to tumorigenesis and BC growth [95].